A patient-level analysis found that negative margins < 2 mm after breast-conserving surgery for ductal carcinoma in situ (DCIS) did not increase ipsilateral recurrence risk compared with margins ≥ 2 ...
October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...
We conducted a retrospective, observational cohort study of women diagnosed with DCIS between 2008 and 2015 treated with BCS. Patient, diagnosis, treatment, and outcome data were abstracted by local ...
A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive ...
Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study A ...
For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...
A diagnosis of ductal carcinoma in situ (DCIS) might seem reassuring compared to invasive breast cancer, but recent research paints a more nuanced picture about this condition that affects roughly ...
A large national study has provided some of the strongest evidence yet on how much healthy tissue should be removed when treating ductal carcinoma in situ (DCIS) with breast-conserving surgery – ...
In this episode of Scrubcast, breast surgeon and surgical oncologist Dr. Irene Wapnir discusses the evolution of breast cancer care, from the widespread use of mastectomy to breast-conserving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results